For example, in human NASH livers, CCN2 localized to areas of ECM in the portal tracts and fibrous septa, where it was predominantly associated with sites of fibrogenesis (i.e., containing activated HSC), resulting in a positive correlation between CCN2 and fibrosis stage [51]. This evidence concerns the gene CCN2 and metabolic dysfunction-associated steatohepatitis.